beta

AVRO

AvroBio Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Market Cap: 59.7 Million

Primary Exchange: NASDAQ

Website: avrobio.com

Shares Outstanding: 44.6 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.3631406408121816

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 1662 trading days

From: 2018-09-26 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud